(E)- and (Z)-7-Arylidenenaltrexones:  Synthesis and Opioid Receptor Radioligand Displacement Assays

The E-isomer of 7-benzylidenenaltrexone (BNTX, 1a) was reported by Portoghese , as a highly selective δ-opioid antagonist. The corresponding Z-isomer 1b was not readily available through direct aldol condensation of naltrexone (6) with benzaldehyde. Using the photochemical methods employed by Lewis...

Full description

Saved in:
Bibliographic Details
Published inJournal of medicinal chemistry Vol. 40; no. 5; pp. 749 - 753
Main Authors Palmer, Robert B, Upthagrove, Alana L, Nelson, Wendel L
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 28.02.1997
Amer Chemical Soc
Subjects
RAT
Online AccessGet full text

Cover

Loading…
More Information
Summary:The E-isomer of 7-benzylidenenaltrexone (BNTX, 1a) was reported by Portoghese , as a highly selective δ-opioid antagonist. The corresponding Z-isomer 1b was not readily available through direct aldol condensation of naltrexone (6) with benzaldehyde. Using the photochemical methods employed by Lewis to isomerize cinnamamides, we have obtained Z-isomer 1b in good yield from E-isomer 1a. A series of (E)- and (Z)-7-arylidenenaltrexone derivatives was prepared to study the effect of larger arylidene groups on opioid receptor affinity in this series. By aldol condensation of naltrexone (6) with benzaldehyde, 1-naphthaldehyde, 2-naphthaldehyde, 4-phenylbenzaldehyde, and 9-anthracaldehyde, the (E)-arylidenes were readily obtained. Photochemical isomerization afforded the corresponding Z-isomers. These compounds were evaluated via opioid receptor radioligand displacement assays. In these assays, the Z-isomers generally had higher affinity and were more δ-selective than the corresponding E-isomers. The (Z)-7-(1-naphthylidene)naltrexone (3b) showed the greatest selectivity (δ:μ ratio of 15) and highest affinity δ-binding (K i = 0.7 nM). PM3 semiempirical geometry optimizations suggest a significant role for the orientation of the arylidene substituent in the binding affinity and δ-receptor selectivity. This work demonstrates that larger groups may be incorporated into the arylidene portion of the molecule with opioid receptor affinity being retained.
Bibliography:Abstract published in Advance ACS Abstracts, February 1, 1997.
ark:/67375/TPS-8WJ5HKLN-D
istex:809F88AC630B5A46BD26BE715EFA0129FE708453
Medline
NIH RePORTER
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-2623
1520-4804
DOI:10.1021/jm960573f